Last reviewed · How we verify
A Double-Blind, Randomized Study to Evaluate the Efficacy and Safety of Lapaquistat or Placebo When Co-Administered With High Dose Statin Therapy in Subjects With Primary Hypercholesterolemia
The purpose of this study is to evaluate lapaquistat acetate, once daily (QD), taken alone or with additional statin therapy on cholesterol levels in treating patients with elevated cholesterol.
Details
| Lead sponsor | Takeda |
|---|---|
| Phase | Phase 3 |
| Status | TERMINATED |
| Enrolment | 649 |
| Start date | 2005-11 |
| Completion | 2007-03 |
Conditions
- Hypercholesterolemia
Interventions
- Lapaquistat acetate and stable statin therapy
- Stable statin therapy
Primary outcomes
- Change from Baseline in Low Density Lipoprotein cholesterol — Week 24 or Final Visit
Countries
United States, Canada, South Africa